'Disappointed' in Allergan poison pill, but we think deal will get done: Valeant CEO
April 23, 2014 at 07:40 AM EDT
Activist investor Bill Ackman and Valeant Pharmaceuticals Chairman and CEO J. Michael Pearson appeared on CNBC's " Squawk Box" to talk about their unsolicited $46 billion takeover offer for Botox-maker Allergan.
